Arthur Fratamico

This profile gathers the share dealings of Arthur Fratamico across 2 companies, led by Panbela Therapeutics, Inc. and Vitae Pharmaceuticals, Inc. Over a trading history stretching from 27 August 2015 to 25 May 2021, the count stands at 6 filings.

The open-market record is one-sided, with 2 purchases worth €70k and not one sale. No amount is published for 1 filing, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 3 share grants.

The record was last updated on 27 May 2021 with a share grant in Panbela Therapeutics, Inc. The most recent open-market purchase was published on 1 September 2020, 2,244 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.